Amici per La Pelle Traier
Paolo A. Ascierto, MD, on Metastatic Melanoma: Ipilimumab Study Results
Paolo A. Ascierto, MD, on Metastatic Melanoma: Ipilimumab Study Results (Ita)
Combination therapy for melanoma - open questions and the SECOMBIT
The importance of biomarkers to optimize treatment with immunotherapy for melanoma
Mechanisms of resistance to checkpoint inhibitors in melanoma
The safety of nivolumab for advanced melanoma
CheckMate 172 trial of nivolumab for advanced melanoma: preliminary results
Fondazione Melanoma Onlus | Made in Sud | Backstage Calendario 2013
Paolo Ascierto per Oncoinfo
Paolo Ascierto a Dr Taxi: da Chicago a Napoli
